Rahmani Rana, Zarrini Gholamreza, Sheikhzadeh Farzam, Aghamohammadzadeh Naser
Laboratory of Microbiology, Department of Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, IR Iran.
Department of Animal Sciences, Faculty of Natural Sciences, University of Tabriz, Tabriz, IR Iran.
Jundishapur J Microbiol. 2015 Feb 20;8(2):e17744. doi: 10.5812/jjm.17744. eCollection 2015 Feb.
Bacteriophages are viruses that attack bacteria and lead to their lysis in an efficient and highly specific manner. These natural enemies of bacteria were used as therapeutic agents before the advent of antibiotics. Currently, with the rapid spread of multi-drug resistant bacteria, phage therapy can be an effective alternative treatment for antibiotic resistant bacteria.
This study evaluated the effectiveness of bacteriophages in removing antibiotic-resistant clinical Escherichia coli strains in vitro and in vivo.
Different samples were taken from bed sore and foot ulcers of patients with diabetes. E. coli strains were isolated and identified by standard methods. The antibiogram was ascertained using the Kirby Bauer disc diffusion method for ten antibiotics. The bacteriophages were isolated from environmental water samples. They were exposed to the host bacteria by the double-layer agar technique (DLA) to observe plaques. Cross reaction of the phages on test E. coli strains was performed to determine broader-spectrum phages. Phage TPR7 was selected for animal trials. Five groups of mice including a control group, bacterial group, phage group, antibiotic therapy group and phage therapy group, were examined.
Ten E. coli strains were isolated from hospital samples. They showed high resistance to the used antibiotics. An effective bacteriophage was isolated for each strain. The cross-reaction showed phages which affect more than six E. coli strains. They can be a good choice for clinical therapeutic use. In animal trials the group challenged with phages after being infected showed similar results as the group treated with gentamicin after being infected. In both groups infection was removed after 48 hours.
According to the results, six strains were resistant to six or seven antibiotics and all strains were at least resistant to two antibiotics. However, for each of these resistant bacteria one bacteriophage was isolated from environmental samples, which showed the effectiveness of bacteriophages to remove clinically resistant E. coli strains. Effective phages in vitro showed effective results in vivo as well.
噬菌体是一类能以高效且高度特异性的方式攻击细菌并导致其裂解的病毒。在抗生素出现之前,这些细菌的天敌就被用作治疗剂。目前,随着多重耐药细菌的迅速传播,噬菌体疗法可能成为治疗抗生素耐药细菌的一种有效替代疗法。
本研究评估噬菌体在体外和体内清除耐抗生素临床大肠杆菌菌株的有效性。
从糖尿病患者的褥疮和足部溃疡处采集不同样本。采用标准方法分离和鉴定大肠杆菌菌株。使用 Kirby Bauer 纸片扩散法测定十种抗生素的药敏谱。从环境水样中分离噬菌体。通过双层琼脂技术(DLA)将它们暴露于宿主细菌以观察噬菌斑。对噬菌体在测试大肠杆菌菌株上进行交叉反应以确定广谱噬菌体。选择噬菌体 TPR7 进行动物试验。检查了五组小鼠,包括对照组、细菌组、噬菌体组、抗生素治疗组和噬菌体治疗组。
从医院样本中分离出 10 株大肠杆菌菌株。它们对所用抗生素表现出高度耐药性。为每个菌株分离出一种有效的噬菌体。交叉反应显示有些噬菌体可影响六种以上的大肠杆菌菌株。它们可能是临床治疗用途的良好选择。在动物试验中,感染后用噬菌体攻击的组与感染后用庆大霉素治疗的组结果相似。两组在 48 小时后感染均被清除。
根据结果,六株菌株对六种或七种抗生素耐药,且所有菌株至少对两种抗生素耐药。然而,对于每一株这些耐药细菌,都从环境样本中分离出一种噬菌体,这表明噬菌体清除临床耐药大肠杆菌菌株的有效性。体外有效的噬菌体在体内也显示出有效结果。